T1	Participants 45 99	new renin inhibitor, and diltiazem in healthy subjects
T2	Participants 357 373	healthy subjects
T3	Participants 451 478	healthy young male subjects
T4	Participants 1131 1176	Fourteen subjects were enrolled and completed
